{
  "id": 2663,
  "text": "472.Lee, K.B., Lee, J.M., Park, C.Y., Cho, H.Y.& Ha, S.Y.Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix.Int $J$ Gynecol Cancer 16, 1184-1187 (2006).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 472.Lee, K.B., Lee, J.M., Park, C.Y., Cho, H.Y.& Ha, S.Y.Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix.Int $J$ Gynecol Cancer 16, 1184-1187 (2006).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于微小浸润性宫颈鳞状细胞癌，淋巴结转移和淋巴管间隙侵袭在临床上具有重要意义。淋巴管间隙侵袭（LVSI）与淋巴结转移的风险显著相关，两者共同影响患者预后的判断与治疗策略的选择。\n\n具体来说，淋巴结转移被视为判断癌症分期及评估复发风险的重要指标。当存在淋巴结转移时，患者的疾病预后往往较差，需加强治疗强度，例如采取辅助放疗或化疗。此外，淋巴管间隙的癌细胞侵袭是肿瘤转移的重要步骤，若检测到LVSI，也提示患者可能具有较高的区域性或远处转移风险。因此，在临床管理中，需要对存在这两种病理学特征的患者进行更加严格的随访和个体化治疗以提高疗效。这些特征的鉴定可以帮助医生在早期阶段更精准地规划手术范围和辅助治疗方案，从而改善患者结局。",
  "query": "对于微小浸润性宫颈鳞状细胞癌，淋巴结转移和淋巴管间隙侵袭在临床上有哪些重要性？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于微小浸润性宫颈鳞状细胞癌，淋巴结转移和淋巴管间隙侵袭在临床上有哪些重要性？\n\n<reference text>: 472.Lee, K.B., Lee, J.M., Park, C.Y., Cho, H.Y.& Ha, S.Y.Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix.Int $J$ Gynecol Cancer 16, 1184-1187 (2006).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于微小浸润性宫颈鳞状细胞癌，淋巴结转移和淋巴管间隙侵袭在临床上具有重要意义。淋巴管间隙侵袭（LVSI）与淋巴结转移的风险显著相关，两者共同影响患者预后的判断与治疗策略的选择。\n\n具体来说，淋巴结转移被视为判断癌症分期及评估复发风险的重要指标。当存在淋巴结转移时，患者的疾病预后往往较差，需加强治疗强度，例如采取辅助放疗或化疗。此外，淋巴管间隙的癌细胞侵袭是肿瘤转移的重要步骤，若检测到LVSI，也提示患者可能具有较高的区域性或远处转移风险。因此，在临床管理中，需要对存在这两种病理学特征的患者进行更加严格的随访和个体化治疗以提高疗效。这些特征的鉴定可以帮助医生在早期阶段更精准地规划手术范围和辅助治疗方案，从而改善患者结局。"
}